Cart
sales@molnova.com
Eravacycline dihydrochloride
CAS No. 1334714-66-7
Eravacycline dihydrochloride( —— )
Catalog No. M32916 CAS No. 1334714-66-7
Eravacycline dihydrochloride (TP-434-046) is a potent and broad-spectrum antibacterial agent against six E. coli (MICs: 0.125-0.25 mg/L).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 353 | In Stock |
|
| 10MG | 588 | In Stock |
|
| 25MG | 1036 | In Stock |
|
| 50MG | 1795 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEravacycline dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEravacycline dihydrochloride (TP-434-046) is a potent and broad-spectrum antibacterial agent against six E. coli (MICs: 0.125-0.25 mg/L).
-
DescriptionEravacycline dihydrochloride (TP-434 dihydrochloride) is a potent and broad-spectrum antibacterial agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1334714-66-7
-
Formula Weight631.48
-
Molecular FormulaC27H33Cl2FN4O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (158.36 mM; Ultrasonic) DMSO : ≥ 50 mg/mL (79.18 mM )
-
SMILESCl.Cl.[H][C@@]12Cc3c(F)cc(NC(=O)CN4CCCC4)c(O)c3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Seifert H, et al. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii. Int J Antimicrob Agents. 2017 Jul 10.?
molnova catalog
related products
-
WAY-354831
WAY-354831 exhibits antibacterial activity.
-
Kasugamycin hydrochl...
Kasugamycin hydrochloride hydrate(Ksg) specifically inhibits translation initiation of canonical but not of leaderless messenger RNAs. Ksg inhibition is thought to occur by direct competition with initiator transfer RNA.
-
ETX2514
ETX2514 (ETX 2514, ETX-2514)?is a covalent, broad-spectrum β-lactamase inhibitor with IC50 of 4, 14 and 190 nM for class A KPC-2, class C AmpC and class D OXA-24, respectively.
